Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MMP24 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | PRKAG1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | MARK1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | S100A10 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | STMN3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ITIH4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ZNF527 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
mRNA | KNSTRN | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | ZNF682 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |